NCT00014131View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Kidney Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

Biological/Vaccine: therapeutic autologous dendritic cells.

Biological/Vaccine: therapeutic autologous dendritic cells. Apheresis procedure collects peripheral blood mononuclear cells (PBMC) for the production of dendritic cell, which are admixed with irradiated tumor cells from autologous tumor cell line for vaccine product.

Trial Locations (1)

92663

Hoag Cancer Center at Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
lead

Lisata Therapeutics, Inc.

INDUSTRY

NCT00014131 - Vaccine Therapy in Treating Patients With Kidney Cancer | Biotech Hunter | Biotech Hunter